Dysregulation of PAD4-mediated citrullination of nuclear GSK3 activates TGF- signaling and induces epithelial-to-mesenchymal transition in breast cancer cells
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dysregulation of PAD4-mediated citrullination of nuclear GSK3 activates TGF- signaling and induces epithelial-to-mesenchymal transition in breast cancer cells
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 110, Issue 29, Pages 11851-11856
Publisher
Proceedings of the National Academy of Sciences
Online
2013-07-02
DOI
10.1073/pnas.1308362110
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Regulation of histone modification and chromatin structure by the p53–PADI4 pathway
- (2012) Chizu Tanikawa et al. Nature Communications
- Regulation of protein stability by GSK3 mediated phosphorylation
- (2011) Chong Xu et al. CELL CYCLE
- Citrullination of Inhibitor of Growth 4 (ING4) by Peptidylarginine Deminase 4 (PAD4) Disrupts the Interaction between ING4 and p53
- (2011) Qin Guo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structural Basis and Specificity of Acetylated Transcription Factor GATA1 Recognition by BET Family Bromodomain Protein Brd3
- (2011) R. Gamsjaeger et al. MOLECULAR AND CELLULAR BIOLOGY
- Genome-Wide Analysis Reveals PADI4 Cooperates with Elk-1 to Activate c-Fos Expression in Breast Cancer Cells
- (2011) Xuesen Zhang et al. PLoS Genetics
- Wnt Signaling Requires Sequestration of Glycogen Synthase Kinase 3 inside Multivesicular Endosomes
- (2010) Vincent F. Taelman et al. CELL
- Transcriptional crosstalk between TGFβ and stem cell pathways in tumor cell invasion: Role of EMT promoting Smad complexes
- (2010) Jonas Fuxe et al. CELL CYCLE
- The SNAG domain of Snail1 functions as a molecular hook for recruiting lysine-specific demethylase 1
- (2010) Yiwei Lin et al. EMBO JOURNAL
- Clinical and biological significance of GSK-3β inactivation in breast cancer—an immunohistochemical study
- (2010) Hanan Armanious et al. HUMAN PATHOLOGY
- Peptidylarginine deiminase 4 and citrullination in health and disease
- (2009) Consuelo Anzilotti et al. AUTOIMMUNITY REVIEWS
- Increased PADI4 expression in blood and tissues of patients with malignant tumors
- (2009) Xiaotian Chang et al. BMC CANCER
- Regulation of Protein Citrullination through p53/PADI4 Network in DNA Damage Response
- (2009) C. Tanikawa et al. CANCER RESEARCH
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- Mechanism of TGF-β signaling to growth arrest, apoptosis, and epithelial–mesenchymal transition
- (2009) Carl-Henrik Heldin et al. CURRENT OPINION IN CELL BIOLOGY
- A SNAIL1–SMAD3/4 transcriptional repressor complex promotes TGF-β mediated epithelial–mesenchymal transition
- (2009) Theresa Vincent et al. NATURE CELL BIOLOGY
- Proteome-wide prediction of acetylation substrates
- (2009) A. Basu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Axin and GSK3- control Smad3 protein stability and modulate TGF- signaling
- (2008) X. Guo et al. GENES & DEVELOPMENT
- Methylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activity
- (2008) X. Zhao et al. GENES & DEVELOPMENT
- Histone Arg Modifications and p53 Regulate the Expression ofOKL38, a Mediator of Apoptosis
- (2008) Hongjie Yao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Regulation of p53 Target Gene Expression by Peptidylarginine Deiminase 4
- (2008) P. Li et al. MOLECULAR AND CELLULAR BIOLOGY
- The glycogen synthase kinase (GSK) 3β represses RNA polymerase I transcription
- (2008) T Vincent et al. ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More